Skip to main content

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Neonatology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1476692

Neonatal Encephalopathy in Aotearoa New Zealand: A review utilising two existing population datasets

Provisionally accepted
Malcolm Battin Malcolm Battin 1*Lynn Sadler Lynn Sadler 1Jutta Van Den Boom Jutta Van Den Boom 2the ANZNN the ANZNN 3
  • 1 Health New Zealand, Te Whatu Ora, Auckland, New Zealand
  • 2 Health New Zealand, Te Whatu Ora, Waikato, Hamilton, New Zealand
  • 3 ANZNN, Sydney, Australia

The final, formatted version of the article will be published soon.

    In Aotearoa New Zealand the Perinatal & Maternal Mortality Review Committee (PMMRC) collects national data on moderate/severe neonatal encephalopathy (NE), including demographic and clinical details such as treatment with therapeutic hypothermia (TH). The Australian and New Zealand Neonatal Network (ANZNN) collects data on infants who receive TH. However, for ANZNN receipt of TH is the entry criteria not severity of NE or gestation. As these datasets have different entry criteria there is potential to combine and gain greater insight into treatment provided nationally for NE.The specific objectives were to:Compare the NE dataset collected by the PMMRC and the ANZNN cooling dataset from all level 2 and 3 NICUs in NZ, to understand differences including the ability to estimate rates of NE over time.Review temporal trends in provision of TH nationally in NZ over the 9-year epoch (2010-2018), including documenting the number/year in both datasets and between centre variations.Assess receipt of TH for NZ infants with moderate to severe NE to ensure it was appropriate and equitable across all groups.The ANZNN dataset is collected in a de-identified manner so analysis was at the aggregate (i.e. total national and/or tertiary NICU) not individual level.601 term infants were identified from the PMMRC dataset and 614 term infants from ANZNN dataset for the study period. The distribution of sex, birthweight, mode of birth, gestation and plurality were similar between the two datasets. However, there was a difference in the numbers by year of birth. ANZNN demonstrated a trend towards more babies over time consistent with greater use of TH. However, PMMRC demonstrated a stable proportion of babies receiving TH.The combined data enabled an estimate to be made of the total NE burden nationally. Moderate and severe NE was documented over the epoch using the consistent PMMRC criteria but the additional ANZNN data illustrated babies cooled outside of moderate to severe NE. The two datasets were definitely not interchangeable for the purpose of NE case ascertainment. There were no major differences demonstrated in the receipt of TH when analysed by ethnicity.

    Keywords: Perinatal asphyxia, encephalopathy, Therapeutic hypothermia, cooling, neonatal encephalopathy, Hypoxic Ischaemic Encephalopathy. 2

    Received: 06 Aug 2024; Accepted: 19 Mar 2025.

    Copyright: © 2025 Battin, Sadler, Van Den Boom and ANZNN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Malcolm Battin, Health New Zealand, Te Whatu Ora, Auckland, New Zealand

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more